1. Home
  2. TAK vs COR Comparison

TAK vs COR Comparison

Compare TAK & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • COR
  • Stock Information
  • Founded
  • TAK 1781
  • COR 2001
  • Country
  • TAK Japan
  • COR United States
  • Employees
  • TAK N/A
  • COR N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • COR Other Pharmaceuticals
  • Sector
  • TAK Health Care
  • COR Health Care
  • Exchange
  • TAK Nasdaq
  • COR Nasdaq
  • Market Cap
  • TAK 43.8B
  • COR 44.0B
  • IPO Year
  • TAK N/A
  • COR N/A
  • Fundamental
  • Price
  • TAK $14.25
  • COR $235.59
  • Analyst Decision
  • TAK
  • COR Buy
  • Analyst Count
  • TAK 0
  • COR 10
  • Target Price
  • TAK N/A
  • COR $254.80
  • AVG Volume (30 Days)
  • TAK 2.0M
  • COR 1.8M
  • Earning Date
  • TAK 10-31-2024
  • COR 11-06-2024
  • Dividend Yield
  • TAK 4.39%
  • COR 0.87%
  • EPS Growth
  • TAK N/A
  • COR 12.46
  • EPS
  • TAK 0.59
  • COR 9.21
  • Revenue
  • TAK $27,433,603,193.00
  • COR $283,830,824,000.00
  • Revenue This Year
  • TAK $4.97
  • COR $12.72
  • Revenue Next Year
  • TAK $0.95
  • COR $7.00
  • P/E Ratio
  • TAK $48.15
  • COR $25.59
  • Revenue Growth
  • TAK 7.28
  • COR 11.56
  • 52 Week Low
  • TAK $12.58
  • COR $182.75
  • 52 Week High
  • TAK $15.08
  • COR $247.66
  • Technical
  • Relative Strength Index (RSI)
  • TAK 44.03
  • COR 64.05
  • Support Level
  • TAK $13.98
  • COR $221.95
  • Resistance Level
  • TAK $14.35
  • COR $236.89
  • Average True Range (ATR)
  • TAK 0.15
  • COR 3.25
  • MACD
  • TAK -0.03
  • COR 2.04
  • Stochastic Oscillator
  • TAK 52.94
  • COR 92.87

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About COR Cencora Inc.

Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Share on Social Networks: